KEGG   DRUG: Tixagevimab
Entry
D11993                      Drug                                   
Name
Tixagevimab (USAN);
Tixagevimab (genetical recombination) (JAN)
Formula
C6488H10034N1746O2038S50
Exact mass
146614.1231
Mol weight
146704.92
Sequence
(Heavy chain)
QMQLVQSGPE VKKPGTSVKV SCKASGFTFM SSAVQWVRQA RGQRLEWIGW IVIGSGNTNY
AQKFQERVTI TRDMSTSTAY MELSSLRSED TAVYYCAAPY CSSISCNDGF DIWGQGTMVT
VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEF
EGGPSVFLFP PKPKDTLYIT REPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPASIEK TISKAKGQPR EPQVYTLPPS
REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
(Light chain)
EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGIP
DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ HYGSSRGWTF GQGTKVEIKR TVAAPSVFIF
PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN SQESVTEQDS KDSTYSLSST
LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC
(Disulfide bridge: H22-H96, H101-H106, H150-H206, H216-L216, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'101-H'106, H'150-H'206, H'226-L'216, H'267-H'327, H'373-H'431, L23-L89, L136-L196, L'23-L'89, L'136-L'196)
  Type
Peptide
Class
Antiviral
 DG03174  Anti-SARS-CoV-2 agent
Remark
Product (mixture): D12262<JP>
Efficacy
Antiviral
  Type
Monoclonal antibody
Comment
Treatment and prevention of SARS-CoV-2 infection
Target
SARS-CoV-2 spike glycoprotein S1 [KO:K25001]
  Pathway
ko03230  Viral genome structure
ko03262  Virion - Coronavirus
Brite
Drug groups [BR:br08330]
 Antiviral
  DG03174  Anti-SARS-CoV-2 agent
   D11993  Tixagevimab
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   Coronavirus spike protein
    D11993  Tixagevimab (USAN)
Other DBs
CAS: 2420564-02-7
PubChem: 497620406
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system